Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 28

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 28
---
.” The Parties have agreed to use their commercially
reasonable efforts to cause the Common Shares to be delisted from Nasdaq, in accordance with applicable laws, rules and regulations, promptly following the completion of the Arrangement.

Dissent Rights

Pursuant to and in
accordance with the Plan of Arrangement, the Interim Order and the provisions of Chapter XIV – Division I of the QBCA (as modified or supplemented by the Interim Order, the Plan of Arrangement and any other order of the Court), Registered
Shareholders have the right to demand the repurchase of their Common Shares in connection with the Arrangement and, if the Arrangement becomes effective, to be paid the fair value of their Common Shares (subject to any applicable withholdings). See
“Dissent Rights.”

A Registered Shareholder who wishes to exercise Dissent Rights must send to the Company a written
notice informing the Company of such Shareholder’s intention to exercise Dissent Rights (the “Dissent Notice”), which Dissent Notice must be received by our Secretary at Repare Therapeutics Inc., 7171 Frederick-Banting,
Building 2, Suite 270, St-Laurent, Québec, Canada H4S 1Z9, Attention: Secretary or by emailinginvestor@reparerx.comby no later than 5:00 p.m. (Montreal time) on January
14, 2026 (or by 5:00 p.m. (Montreal time) on the second Business Day immediately preceding the date that any adjourned or postponed Special Meeting is reconvened. Failure to strictly comply with the requirements set forth in Chapter XIV –
Division I of the QBCA (as modified or supplemented by the Interim Order, the Plan of Arrangement and any other order of the Court) may result in the loss of Dissent Rights.

Anyone who is a Beneficial Shareholder who wishes to exercise Dissent Rights should be aware that only Registered Shareholders are entitled to
exercise Dissent Rights. Accordingly, a Beneficial Shareholder desiring to exercise Dissent Rights must make arrangements for the Common Shares beneficially owned by that holder to be registered in the name of the Shareholder prior to the time the
Dissent Notice is required to be received by the Company or, alternatively, make arrangements for the registered holder of such Common Shares to exercise Dissent Rights on behalf of the holder. In such case, the Dissent Notice should specify the
number of Common Shares. A Diss